Market potential of point-of-care testing

The in vitro diagnostics industry plays a more and more important role, applying new consolidated findings from molecular medicine and genome research. On the one hand, there is a trend towards centralising laboratory diagnostics, and on the other hand laboratory tests are returning to point-of-care testing. Hence, the point-of-care market of around 5 Mrd. US$ has a growth rate of 10.5% per year.